FDA to weigh easing limits on unproven peptides favored by RFK Jr. and MAHA supporters PBS News Beyond the Headlines: FDA Warning Letters to GLP 1 Compounders Spencer Fane FDA Is Expected to Lift Restriction on Peptides, Heeding RFK Jr.'s Wishes The New York Times In 2023, the FDA deemed 19 peptides too unsafe to be dispensed by compounding pharmacies. Now, under RFK Jr., the agency is poised to reverse itself despite the fact that few of the Federal Food, Drug, and Cosmetic Act (FDCA).* BPC 157 Capsules Vios Compounding